PETALING JAYA: Malaysia’s defence against dengue fever has been strengthened with the launch of the country's first vaccine against the disease.
Takeda Malaysia’s dengue tetravalent vaccine (live attenuated) Qdenga was officially launched on Tuesday (June 11).
The vaccine, approved by the Drug Control Authority (DCA), is designed to protect against all four dengue virus serotypes.
It requires two doses at a three-month interval and can be administered to those aged four and above.
Takeda Malaysia & Singapore country general manager Dr Lynette Moey said the impact of dengue fever cannot be overstated.
“It has inflicted a heavy toll on at-risk populations, with Asia bearing a significant burden of the global dengue crisis,” she said at the media launch of the vaccine here.
"The World Health Organization (WHO) has recognised dengue as one of the top 10 threats to global health, underscoring the urgency of our collective efforts to address this pressing issue.
“In the wake of the enduring impact of the recent pandemic, we are acutely aware of the need to confront health threats with resilience and innovation,” she added.
Dr Moey said the vaccine will be available at general practitioner clinics and private hospitals.
“We cannot disclose the pricing. The healthcare facilities will determine their price,” she said when asked about the cost of the vaccine.
She said it would be “extremely equitable” in terms of affordability.
Dr Moey said the company is also open to working with the Health Ministry on bringing the vaccine to the public healthcare sector.
She said clinical trials had shown that the vaccine successfully prevented 80.2% of symptomatic dengue cases at 12 months after vaccination.
After a period of four and a half years, the vaccine’s efficacy was at 84.1% against hospitalisation and 61.2% against symptomatic cases, she added.
The vaccine has been approved in more than 30 countries, including the European Union, the United Kingdom, Brazil, Argentina, Indonesia, Thailand and Vietnam.
There was an 86.3% increase in dengue cases in Malaysia last year over 2022.
In the first quarter this year, 41,565 cases and 28 fatalities were reported in the country.
